Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Favorable phase I data presented for Bay-43-9006 at ASCO

May 30, 2001

Telik begins phase II trial of TLK-286 for treatment of ovarian cancer

May 30, 2001

First human results for rhAngiostatin support its further development

May 29, 2001

NK-30424 analogues useful as antitumor and antiinflammatory agents

May 28, 2001

Investigational anticancer agent phenoxodiol enters first U.S. trial

May 28, 2001

Tyrosine kinase inhibitors useful for immunological disorders and cancer

May 25, 2001

Nonpeptide inhibitors of methionyl aminopeptidase useful for angiogenesis-related conditions

May 25, 2001

Revived hope for tesmilifene in breast cancer at YM BioSciences

May 25, 2001

Findings from first phase I clinical trial of Panzem presented at ASCO meeting

May 25, 2001

Hybrigenics and Institut Curie open laboratory for cancer proteomics research

May 25, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
In the clinic for June 12, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Anixa, Beone, Bioinvent, Blossomhill, C4, Cellectis, Climb, Elixiron,...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...